Steingrimur Stefansson

Employment

• HeMemics Biotechnologies Inc. dir r&D
  2015 - Present

Education

• University of Iceland BS
  1983 - 1984

Projects & Funding

Projects & funding information is unavailable.

Publications (17)

• Novel approaches to thrombolysis based on modulation of endogenous fibrinolysis
  DOI: 10.1097/00019501-199802000-00006
  +Save
• The serpin PAI-1 inhibits cell migration by blocking integrin αvβ3 binding to vitronectin
  DOI: 10.1038/383441a0
  +Save
• The inhibition of clotting complexes of the extrinsic coagulation cascade by the phospholipase A2 isoenzymes from venom
  DOI: 10.1016/0049-3848(89)90056-X
  +Save
• The basic phospholipase A2 from Naja nigricollis venom inhibits the prothrombinase complex by a novel nonenzymic mechanism
  DOI: 10.1021/bi00485a024
  +Save
• Targeting of Venom Phospholipases: The Strongly Anticoagulant Phospholipase A2 from Naja nigricollis Venom Binds to Coagulation Factor Xa to Inhibit the Prothrombinase Complex
  DOI: 10.1006/abbi.1999.1345
  +Save
• Targeting Antibodies to Carbon Nanotube Field Effect Transistors by Pyrene Hydrazide Modification of Heavy Chain Carbohydrates
  DOI: 10.1155/2012/490175
  +Save
• Specific Binding of Alzheimer’s Abeta Peptide Fibrils to Single Walled Carbon Nanotubes
  DOI: 10.5772/54650
  +Save
• Rapid Diagnosis of E. Coli using Carbon Nanotube Field Effect Transistor Direct Binding Assay
  DOI: 10.1557/opl.2012.668
  +Save
• Plasminogen Activator Inhibitor-1 in Tumor Growth, Angiogenesis and Vascular Remodeling
  DOI: 10.2174/1381612033454621
  +Save
• 56 Neurosepin, a specific brain-associated inhibitor of tissue plasminogen activator (tPA)
  DOI: 10.1016/S0268-9499(97)80171-3
  +Save